Faulty reasoning signals

• Attempt to Sell a Product or Service - 45.1%
• Negativity Bias - 20.2%
• Unattributed Quote - 11.9%

Article text

White House reviewing top contenders to lead FDA

Heidi Overton, Jeffrey Vacirca, and Stephen Ferrara are among finalists

Sarah Silbiger/Getty Images

Washington Correspondent

Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care. Confidential tips can be sent on Signal at danielp.100.

WASHINGTON — The top contenders to lead the Food and Drug Administration have been sent to the White House for a final review and decision, according to a person familiar with the process.

The finalists include Heidi Overton, a White House adviser; Jeffrey Vacirca, an oncologist and health system executive; and Stephen Ferrara, a health affairs official at the Defense Department.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Totals $468 per year

for 3 months, then $399/year

Savings start at 25%!

$300 Annually per user

To read the rest of this story subscribe to STAT+.

FDA , HHS , Pharmaceuticals , Policy , STAT+ , White House

Submit a correction request Reprints

STAT Plus: In private meeting, Trump officials push to onshore generic drugmaking

STAT Plus: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms

STAT Plus: Medicare takes another swing at 340B cuts to hospitals

STAT Plus: Elevance sues government over $115 million tied to Medicare Advantage star ratings

STAT Plus: Anthropic releases Claude Science, a product aimed at researchers, the pharma industry